436 related articles for article (PubMed ID: 32693433)
1. (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.
White SK; Schmidt RL; Walker BS; Hanson KE
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009833. PubMed ID: 32693433
[TBL] [Abstract][Full Text] [Related]
2. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
Cruciani M; Mengoli C; Barnes R; Donnelly JP; Loeffler J; Jones BL; Klingspor L; Maertens J; Morton CO; White LP
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009551. PubMed ID: 31478559
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.
He S; Hang JP; Zhang L; Wang F; Zhang DC; Gong FH
J Microbiol Immunol Infect; 2015 Aug; 48(4):351-61. PubMed ID: 25081986
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
White PL; Price JS; Posso RB; Barnes RA
Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
[TBL] [Abstract][Full Text] [Related]
7. Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.
Lahmer T; Held J; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Dec; 181(11-12):815-821. PubMed ID: 27619810
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of serum (1,3)-beta-d-glucan for neonatal invasive candidiasis: systematic review and meta-analysis.
Cohen JF; Ouziel A; Matczak S; Brice J; Spijker R; Lortholary O; Bougnoux ME; Toubiana J
Clin Microbiol Infect; 2020 Mar; 26(3):291-298. PubMed ID: 31539634
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits.
Bamba Y; Nagano K; Moro H; Ogata H; Hakamata M; Shibata S; Koizumi T; Aoki N; Ohshima Y; Watanabe S; Nakamura T; Kobayashi S; Hoshiyama Y; Koya T; Takada T; Kikuchi T
PLoS One; 2021; 16(8):e0255172. PubMed ID: 34437556
[TBL] [Abstract][Full Text] [Related]
10. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J
Cochrane Database Syst Rev; 2015 Oct; (10):CD009551. PubMed ID: 26424726
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
12. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J
Cochrane Database Syst Rev; 2015 Sep; (9):CD009551. PubMed ID: 26343815
[TBL] [Abstract][Full Text] [Related]
13. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two β-D-glucan assays for detecting invasive fungal diseases in immunocompromised patients.
Song J; Kim S; Park J; Park Y; Kim HS
Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115415. PubMed ID: 34082306
[TBL] [Abstract][Full Text] [Related]
15. Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.
Archer HA; Smailagic N; John C; Holmes RB; Takwoingi Y; Coulthard EJ; Cullum S
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010896. PubMed ID: 26102272
[TBL] [Abstract][Full Text] [Related]
16. Beta-d-Glucan for Diagnosing
Mercier T; Guldentops E; Patteet S; Beuselinck K; Lagrou K; Maertens J
J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30918045
[TBL] [Abstract][Full Text] [Related]
17. Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.
de Heer K; Gerritsen MG; Visser CE; Leeflang MM
Cochrane Database Syst Rev; 2019 May; 5(5):CD012399. PubMed ID: 31107543
[TBL] [Abstract][Full Text] [Related]
18. Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy.
Manzotti C; Casazza G; Stimac T; Nikolova D; Gluud C
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012546. PubMed ID: 31283001
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of β-d-Glucan (Fungitell) Testing Among Patients With Hematologic Malignancies or Solid Organ Tumors: A Systematic Review and Meta-Analysis.
White SK; Walker BS; Hanson KE; Schmidt RL
Am J Clin Pathol; 2019 Feb; 151(3):275-285. PubMed ID: 30307463
[TBL] [Abstract][Full Text] [Related]
20. What should be the optimal cut-off of serum 1,3-β-D-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?
Metan G; Koç AN; Atalay A; Kaynar LG; Ozturk A; Alp E; Eser B
Scand J Infect Dis; 2012 May; 44(5):330-6. PubMed ID: 22188426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
